Walleye Capital’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $25.9M | Buy |
296,256
+44,784
| +18% | +$3.91M | 0.1% | 92 |
|
2025
Q1 | $17.2M | Buy |
251,472
+102,526
| +69% | +$7M | 0.08% | 129 |
|
2024
Q4 | $11.6M | Sell |
148,946
-218,911
| -60% | -$17M | 0.03% | 230 |
|
2024
Q3 | $24.7M | Buy |
367,857
+179,392
| +95% | +$12M | 0.05% | 76 |
|
2024
Q2 | $21.4M | Buy |
188,465
+36,387
| +24% | +$4.13M | 0.04% | 89 |
|
2024
Q1 | $21.1M | Buy |
152,078
+57,416
| +61% | +$7.96M | 0.04% | 91 |
|
2023
Q4 | $11.7M | Sell |
94,662
-117,521
| -55% | -$14.6M | 0.02% | 170 |
|
2023
Q3 | $19.8M | Buy |
+212,183
| New | +$19.8M | 0.05% | 72 |
|
2023
Q2 | – | Hold |
0
| – | – | – | 2284 |
|
2023
Q1 | – | Hold |
0
| – | – | – | 2294 |
|
2022
Q4 | – | Sell |
-6,041
| Closed | -$487K | – | 2253 |
|
2022
Q3 | $487K | Sell |
6,041
-11,955
| -66% | -$964K | 0.01% | 1062 |
|
2022
Q2 | $1.34M | Buy |
+17,996
| New | +$1.34M | 0.04% | 489 |
|
2022
Q1 | – | Sell |
-7,392
| Closed | -$992K | – | 2287 |
|
2021
Q4 | $992K | Buy |
7,392
+824
| +13% | +$111K | 0.03% | 583 |
|
2021
Q3 | $898 | Buy |
+6,568
| New | +$898 | 0.03% | 489 |
|
2020
Q3 | – | Sell |
-5,740
| Closed | -$582K | – | 855 |
|
2020
Q2 | $582K | Sell |
5,740
-1,180
| -17% | -$120K | 0.13% | 200 |
|
2020
Q1 | $466K | Sell |
6,920
-3,480
| -33% | -$234K | 0.1% | 172 |
|
2019
Q4 | $569K | Buy |
+10,400
| New | +$569K | 0.04% | 164 |
|
2019
Q3 | – | Sell |
-9,480
| Closed | -$355K | – | 630 |
|
2019
Q2 | $355K | Sell |
9,480
-1,244
| -12% | -$46.6K | 0.04% | 67 |
|
2019
Q1 | $319K | Buy |
+10,724
| New | +$319K | 0.05% | 48 |
|